| ac8a98be-edb9-423a-b328-a610ee2499b5 | e9bbc4df-9bf7-43fe-9f1a-e774bfd28b40 | 0092074 | DOENCA LINFOPROLIFERATIVA RARA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 227386f3-f8fd-4e03-81ca-ee55143e9279 | d2cebac9-009c-44db-ba94-05ed0d95a8f0 | 0092075 | DOENCA MIELOPROLIFERATIVA RARA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 0f3fbf6c-9fc6-4d5d-8bd6-a51ce4448adf | 3f79176a-bd9a-499c-950c-297b856ff464 | 0092076 | DOENCA MIELOPROLIFERATIVA RARA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c88318ef-ac29-4203-866e-34a57ffd2951 | 24b3b3ad-1832-4d84-8b36-b538510f5825 | 0092077 | F BLASTICA LEUC MIEL CR(COM TRAT ANT 2LINHA) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 143483ad-f381-433c-a257-7bc230973289 | cdfe5241-9351-4860-b47a-c9b527e6b040 | 0092078 | F BLASTICA LEUC MIEL CR(INCLUI PROFILATICOS) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b2f22163-9d0c-41a1-bbbe-39e84a62a691 | 48d457d8-2aa0-49c5-a6de-6f4e7874179d | 0092079 | F BLASTICA LEUC MIEL CR(SEM TRAT ANT 2LINHA) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b335a599-3ff5-45ec-997e-457b80ecef2a | d452b6b7-e51b-4a59-bc61-1801a0620c40 | 0092080 | F CR LEUC MIEL CR (CONTR SANGUINEO OU CITOGENETICO) 1 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 96a61093-0e44-4a93-a781-21bff1ba68cd | 6379f4ee-5701-4704-8b72-53d757e177c0 | 0092081 | F CR LEUC MIELOIDE CR(CONT SANGUINEO) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 623263df-350c-4cf0-bf6a-65d74dfa9fa1 | c838f54e-373b-4c37-bb15-17d9babbc62b | 0092082 | F TRANSF LEUC MIEL CR(COM TRAT ANTERIOR 2L) 1LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 4780862e-30cc-46b9-9c5c-3f026166ef0c | 551f04d2-6d01-46e6-96a4-cd9c9ecd9147 | 0092083 | F TRANSF LEUC MIEL CR(INCL ANTIB PROFIL) 2 LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a73c7b22-e284-41cc-88f9-a573fa125cf1 | 6c2b2b47-82a6-4445-82b3-a10308ee25de | 0092084 | F TRANSF LEUC MIEL CR(SEM TRAT ANTERIOR 2L) 1LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 93343123-48cb-4bad-a371-721b0c4afb38 | 1974558c-1bd6-48db-8c0f-d248d34443f0 | 0092085 | FASE CRONICA LEUCEMIA MIELOIDE CRONICA (CONTROLE SANGUINEO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| c96632e3-77fc-4815-9c26-1e74e40d7987 | cda29005-3f5c-49ee-a8f4-9bacb1d914c9 | 0092086 | FATOR ESTIMULANTE DO CRESCIMENTO DE COLONIAS DE GRANULOCITOS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| b30fcddc-5be4-4a2a-8246-e47345cb59c9 | fa3904f1-0864-4bff-a911-82c2e50fdf94 | 0092087 | HORMONIOTERAPIA ADJUVANTE À RADIOTERAPIA EXTERNA DO ADENOCARCINOMA DE PRÓSTATA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| d52e8736-fb79-49c9-a834-c0311c49a97a | 29012db1-3e6d-4100-b8b9-856532260059 | 0092088 | HORMONIOTERAPIA DE CARCINOMA DE MAMA ESTADIO II | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2e8be38a-67ef-4842-9746-be60cd04a2bb | fa5e12bf-4231-4a10-98b1-7d2c453a7e6f | 0092089 | HORMONIOTERAPIA DE CARCINOMA DE MAMA ESTADIO III CLINICO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f8e74fc5-220b-44e0-84c6-b84f58acea58 | 86d19982-36ba-425f-8fba-47aee7e17f7c | 0092090 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 34051c18-a8ed-4c8f-a7e7-d7f910590bb7 | 94ccd104-6d21-4c96-bef7-9085c691bbf9 | 0092091 | HORMONIOTERAPIA DO ADENOCARCINOMA DE PRÓSTATA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 61f27ec2-1322-4517-b827-7cd98fa520ba | f3228feb-b175-44b8-b5b8-c6e2db9205bd | 0092092 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO - 2ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 297f9a78-7b80-4f0d-8735-774728061dae | a376e8a3-bf22-424b-bd4f-eb83b353946b | 0092093 | HORMONIOTERAPIA DO CARCINOMA DE MAMA AVANÇADO- 1ª LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fb935d9a-caa3-4bb8-8309-5b503479c463 | 8a5ec76d-45cb-486a-ad9b-4855577f3cbf | 0092094 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| fd080651-177a-4439-8ec6-6ec2626fde8e | <span class="null">NULL</span> | 0092095 | HORMONIOTERAPIA DO CARCINOMA DE MAMA EM ESTÁDIO I | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| cce5edc2-fda1-471f-a0a0-981e608327cd | 0f3517f1-4678-4fee-bbb4-5462476f7cb1 | 0092096 | HORMONIOTERAPIA PRÉVIA À RADIOTERAPIA EXTERNA DO ADENOCARCINOMA DE PRÓSTATA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 114fddd7-4a74-450b-b097-8a1547a9b675 | db99bc09-6c39-4f0d-a679-291b6630a265 | 0092097 | IMPLANTAÇÃO DE HALO PARA RADIOCIRURGIA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2e504138-d669-4deb-a82f-a26bfea703e3 | <span class="null">NULL</span> | 0092098 | INIBIDOR DA OSTEOLISE | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 92a11a2f-27e5-4eb9-8446-c75686483a5f | <span class="null">NULL</span> | 0092099 | INTERNAÇÃO P/ RADIOTERAPIA EXTERNA (COBALTOTERAPIA/ACELERADOR) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a5b60384-09dc-435a-b840-6d8573e2efbe | <span class="null">NULL</span> | 0092100 | IRRADIAÇÃO DE CORPO INTEIRO PRÉ TRANSPLANTANTE DE MEDULA ÓSSEA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ef0c08e3-f0bc-4c85-81a3-204c6c36ede0 | dab6e7eb-ed08-4dfd-9023-6f63c2c8d19e | 0092101 | IRRADIAÇÃO DE MEIO CORPO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9784f08a-030f-41ef-829c-e050fe6a589b | a090e0a4-5567-46e9-b7ac-f46c668dbe80 | 0092102 | IRRADIAÇÃO DE PELE TOTAL | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 937f6251-6247-4071-87d3-ddd671158cbf | <span class="null">NULL</span> | 0092103 | LEUCEMIA LINFOCITICA CRONICA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5589d078-ac01-4d7f-b282-58445bfa78f5 | <span class="null">NULL</span> | 0092104 | LEUCEMIA LINFOCITICA CRONICA - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5db93a88-fc48-46c4-9bda-33b1d18432a7 | 651a0e64-53ef-41fd-a1de-93eadd616c85 | 0092105 | LEUCEMIA PRO-MIELOCITICA AGUDA - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| ba81db52-9940-4060-8644-0055ad1222dc | 2ce11869-7e04-43f4-8756-cee860899591 | 0092106 | LEUCEMIA PRO-MIELOCITICA AGUDA - FASES SUBSEQUENTES | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 612e62b9-352b-4267-ad0a-e3198dbecd5a | 5bcf5bc2-e44e-412c-bbd9-94a1ab4e1de0 | 0092107 | LEUCEMIAS AGUDAS | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a1dddc61-463f-4d9e-8c8e-e5f854f8c0b7 | 72e43002-9932-456f-9ceb-030cf0197217 | 0092108 | LEUCEMIAS AGUDAS (1A RECIDIVA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 9c9f5b62-1868-41fb-a338-858a69146bbc | 1bbf826b-55cb-40f2-b94b-9ddcbbc81d84 | 0092109 | LEUCEMIAS AGUDAS (3A RECIDIVA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2ccd52e8-997f-4614-809d-b49f02152e6d | 466013b6-06b3-49f0-88c8-2bad549ed79a | 0092110 | LINFOMA NAO HODGKIN DE BAIXO GRAU DE MALIGNIDADE - 2A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f10856fa-2316-4bc7-a78d-a368ad8ecf47 | 4271f2fc-332e-4a1c-8768-1003e3db136f | 0092111 | LINFOMA NAO HODGKIN DE BAIXO GRAU DE MALIGNIDADE - 1A LINHA | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 90e9d8cc-643d-4b12-a5a3-982d6c373797 | 13f9f44f-68e5-4b97-928f-a697d2410563 | 0092112 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 4db61fb9-d69d-4d45-b679-0a16e8f24cb2 | <span class="null">NULL</span> | 0092113 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO O | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 6bd773a3-356b-4437-bec0-54cb71fec8c3 | 68a07bf2-1d01-4909-b16a-5518183273c2 | 0092114 | LINFOMA NAO HODGKIN DE GRAUS DE MALIGNIDADE INTERMEDIARIO E | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 5c656814-235a-4e71-b980-0e7265a8ac24 | 5b821531-8936-4ae4-b8de-8829cca90e60 | 0092115 | MASCARA/IMOBILIZAÇÃO PERSONALIZADA ( POR TRATAMENTO) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| f204512c-63b5-4327-a88a-f141d00fde02 | c6a5bc9a-852f-43da-8447-adf149e1fe6e | 0092116 | MELANOMA MALIGNO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| a32a6cb7-7371-4cfe-816d-b3055d4b7ff5 | dc07324d-5227-4192-bb0a-624cc2c655b7 | 0092117 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2d64ab70-9b56-4c4f-a4bb-51774e2ce6a2 | 7356e717-154c-4c6d-8cff-561306902d8c | 0092118 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO (ADENOCARCINOMA) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 88d31a42-4db4-4fc1-ae43-13f8fd4cccd6 | <span class="null">NULL</span> | 0092119 | METASTASE DE TUMOR PRIMARIO DESCONHECIDO (CARCINOMA EPIDERMO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 2da64197-1777-4713-9e74-75e79b53008d | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0092120 | MMONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTADIO II(ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 491469ce-6bde-472b-8260-5ea0e40a1cf8 | d27a2eb7-ed35-4ef4-a14f-279f202c9249 | 0092121 | MOLDAGEM EM COLO E / OU CORPO UTERINO | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 573e4ae2-ecae-4da6-b994-fca9b74d3a56 | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0092122 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTÁDIO I (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |
| 60a951f6-e4af-43a1-82c9-2eabc78caa30 | ecdb9634-a5c8-45b2-ba7c-7194d02b3eb5 | 0092123 | MONOQUIMIOTERAPIA DO CARCINOMA DE MAMA HER-2 POSITIVO EM ESTADIO III (ADJUVANTE) | 1 | 2024-07-30T19:45:37.496395+00:00 | 2024-07-30T19:45:37.496395+00:00 |